The USP Drug Classification PLUS is an offering from USP that provides online, interactive access to the USP Drug Classification (an independent drug classification of FDA-approved drugs, organized by categories and classes) with:
The Latest
The percentage of Humana Medicare Advantage members enrolled in plans rated 4 stars or higher for 2025 has dropped significantly, which is expected to negatively affect 2026 revenues.
Blue Shield of California will purchase Fresenius Kabi's Humira biosimilar directly from the manufacturer, a deal that will cut costs and improve patient adherence, the insurer said.
Over the last month, California Gov. Gavin Newsom has signed 17 bills pertaining to the deployment and regulation of generative AI technology, including legislation that will require health insurers to ensure that physicians supervise the use of AI tools that…
Consortium Health Plans has named Lori Schoonmaker as CEO.
Opioid use disorder (OUD) continues to impose a financial burden on the U.S. health care system, with direct health care costs estimated at $63 billion annually. A significant portion of these costs stem from hospitalizations related to withdrawal management and…
Elevance is planning to expand its operations in Indianapolis by investing $11.9 million in two sites in the city, Inside Indiana Business reported Sept. 30.
Premera Blue Cross will no longer offer Medicare Advantage plans in 2025.
In 22 states and Washington, D.C., there will be fewer Medicare Advantage plans available in 2025 than in 2024, according to CMS data.
UnitedHealthcare's national prior authorization gold-card program went into effect Oct. 1.